Skip to main content

Table 1 Clinical and pathological characteristics

From: Exploring the value of new preoperative inflammation prognostic score: white blood cell to hemoglobin for gastric adenocarcinoma patients

Characteristicsn (%) or Means ± SD
Sex
 Male703 (76.1%)
 Female221 (23.9%)
Age, yrs.60.9 ± 11.2
Body mass index (kg/m2)21.9 ± 3.3
ASA scores
 1335 (38.4%)
 2536 (58%)
 333 (3.6%)
Comorbidities
 Yes249 (26.9%)
 No675 (73.1%)
Tumor location
 Upper221 (23.9%)
 Middle153 (16.6%)
 Lower440 (47.6%)
 Mix110 (11.9%)
WHR3.2 ± 2.1
PLR153.7 ± 77.6
LMR4.4 ± 1.9
NLR2.6 ± 2.2
Type of surgery
 Total gastrectomy447 (48.4%)
 Partial gastrectomy477 (51.6%)
Tumor size (cm)4.6 ± 2.5
Adjuvant chemotherapy
 Yes408 (44.2%)
 No516 (55.8%)
Pathological T stage
 T1232 (25.1%)
 T2101 (10.9%)
 T3279 (30.2%)
 T4a312 (33.8%)
Pathological N stage
 N0359 (38.9%)
 N1134 (14.5%)
 N2143 (15.5%)
 N3288 (31.2%)
Pathological TNM stage
 IA195 (21.1%)
 IB72 (7.8%)
 IIA117 (12.7%)
 IIB104 (11.3%)
 IIIA98 (10.6%)
 IIIB159 (17.2%)
 IIIC179 (19.4%)
  1. SD Standard deviation
  2. ASA American Society of Anesthesiologists
  3. WHR White blood cell to hemoglobin ratio was calculated using the following formula: (white blood cell count [number/mm3]) / (10*hemoglobin level [g/L])
  4. PLR The platelet to lymphocyte ratio was defined as the absolute platelet count divided by the absolute lymphocyte count
  5. LMR The lymphocyte to monocyte ratio was defined as the absolute lymphocyte count divided by the absolute monocyte count
  6. NLR The neutrophil to lymphocyte ratio was defined as the absolute neutrophil count divided by the absolute lymphocyte